Cargando…
LPTO-10. ASSESSMENT OF LEPTOMENINGEAL CARCINOMATOSIS DIAGNOSIS AND OUTCOMES FROM 2005 TO 2015 AT THE OHIO STATE UNIVERSITY
BACKGROUND: Leptomeningeal carcinomatosis (LMC) is a complication of solid tumor malignancies where tumors metastasize to the leptomeninges. LMC complicates 4–15% of malignancies with incidence increasing as survival of patients with advanced cancer improves. Diagnostic methods include magnetic reso...
Autores principales: | Williams, Nicole, Rinehardt, Hannah, Morgan, Evan, Kassem, Mahmoud, Palettas, Marilly, Puduvalli, Vinay, Giglo, Pierre, Lustberg, Maryam, Wesolowski, Robert, Sardesai, Sagar, Stover, Daniel, Vandeusen, Jeffrey, Bazan, Jose, Ramaswamy, Bhuvaneswari, Noonan, Anne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213376/ http://dx.doi.org/10.1093/noajnl/vdz014.033 |
Ejemplares similares
-
Clinical impact of interruption in adjuvant Trastuzumab therapy in patients with operable HER-2 positive breast cancer
por: Sardesai, Sagar, et al.
Publicado: (2020) -
Assessment of outcomes and novel immune biomarkers in metaplastic breast cancer: a single institution retrospective study
por: Morgan, Evan, et al.
Publicado: (2020) -
Estrogen Receptor Beta (ERβ): A Ligand Activated Tumor Suppressor
por: Mal, Rahul, et al.
Publicado: (2020) -
LPTO-09. INTRATHECAL TOPOTECAN FOR LEPTOMENINGEAL METASTASIS IN SOLID TUMORS: THE MD ANDERSON EXPERIENCE
por: Sinicrope, Kaylyn D, et al.
Publicado: (2019) -
LPTO-01. LEPTOMENINGEAL METASTASIS FROM OVARIAN CARCINOMA TREATED WITH SYSTEMIC HIGH-DOSE METHOTREXATE
por: Coffee, Elizabeth, et al.
Publicado: (2019)